Acadia Pharma (ACAD) Misses Q1 EPS by 3c
Tweet
Share
E-mail
Get Alerts ACAD Hot Sheet
Price: $26.41 --0%
Revenue Growth %: +19.3%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +19.3%
Financial Fact:
Loss from operations: -72.4M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Acadia Pharma (NASDAQ: ACAD) reported Q1 EPS of ($0.45), $0.03 worse than the analyst estimate of ($0.42).
For earnings history and earnings-related data on Acadia Pharma (ACAD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- UBS Upgrades Bajaj Finance Ltd. (BAF:IN) to Neutral
- Oppenheimer Starts Teva Pharma (TEVA) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
